Concepedia

Riccardo Zanin

RZ

16

Publications

892

Citations

13

H-Index

2017

Active since

Affiliations

Fondazione IRCCS Istituto Neurologico Carlo Besta(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Università Cattolica del Sacro Cuore

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Riccardo Zanin is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, orthopaedics, and rehabilitation.

ORCID

Top concepts

Publications per year

2017–2023

16

Publications

16

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello et al. · The Lancet Neurology · 2021 · 237 citations

, , +2

Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

Lorenzo Maggi, Luca Bello, Silvia Bonanno et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 186 citations · Full text

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 96 citations · Full text

, , +6

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data

Marika Pane, Giorgia Coratti, Claudia Brogna et al. · PLoS ONE · 2018 · 83 citations · Full text

Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients

Silvia Bonanno, Stefania Marcuzzo, Claudia Malacarne et al. · Biomedicines · 2020 · 46 citations · Full text

Rows per page

1–5 of 16